Shelly Lomax
Optometrist · Anderson, SCNPI 1528410461
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $47.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$733
- Sun Pharmaceutical Industries Inc.$544
- Alcon$487
- AbbVie$471
- Bausch & Lomb, A Division Of Bausch Health US, LLC$452
- Coopervision Inc.$336
- plus $3K from 20 others
What the payments were for
- Consulting fees$200%
- Food & beverage$5,85297%
- Gifts$190%
- Entertainment$1142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 9 | $733 |
| Sun Pharmaceutical Industries Inc. | 9 | $544 |
| Alcon | 8 | $487 |
| AbbVie(2 entities) | 22 | $471 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $452 |
| Coopervision Inc. | 5 | $336 |
| Biotissue Holdings Inc. | 4 | $318 |
| Bausch & Lomb Americas Inc. | 8 | $304 |
| Amgen(2 entities) | 9 | $285 |
| Dompe US, Inc. | 3 | $270 |
| Oyster Point Pharma, Inc. | 5 | $255 |
| Mallinckrodt Hospital Products Inc. | 6 | $253 |
| Sight Sciences, Inc. | 2 | $250 |
| Novartis | 11 | $183 |
| Shire North American Group Inc | 4 | $141 |
| Apellis Pharmaceuticals, Inc. | 1 | $122 |
| Optos, Inc. | 1 | $114 |
| LKC Technologies, Inc. | 1 | $103 |
| Integra Lifesciences Corporation | 1 | $85 |
| Harrow Eye, LLC | 4 | $82 |
| Tarsus Pharmaceuticals, Inc. | 3 | $64 |
| Carl Zeiss Meditec USA, Inc. | 1 | $58 |
| Rayner Intraocular Lenses Limited | 2 | $37 |
| Thea Pharma Inc. | 1 | $29 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$425
- CEQUA$357
- Oxervate$245
- PANORAMIC OPHTHALMOSCOPE$228
- OCT OPHTHALMOSCOPE$228
- TYRVAYA$214
- OMNI(R) SURGICAL SYSTEM (US)$154
- Prokera$129
- AmnioGraft$129
- TOTAL30$125
- SIMBRINZA$125
- Rhopressa$125
- Rocklatan$125
- BIOTRUE ONE DAY$125
- VYZULTA$123
- ACTHAR$122
- Syfovre$122
- TEPEZZA$120
- NFC-700$114
- INFUSE$106
How this compares
$6,005 in reported general payments places this provider in the 90th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 136 | $167,030 |
| XiidraLifitegrast | 49 | $51,366 |
| Cyclosporine | 102 | $49,513 |
| LumiganBimatoprost | 20 | $14,272 |
| TyrvayaVarenicline Tartrate | 19 | $11,546 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 38 | $9,315 |
| Latanoprost | 764 | $8,088 |
| Alphagan PBrimonidine Tartrate | 20 | $7,323 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 27 | $4,936 |
| Travoprost | 27 | $4,454 |
| VyzultaLatanoprostene Bunod | 15 | $4,407 |
| Lotemax SmLoteprednol Etabonate | 16 | $3,961 |
| TafluprostTafluprost/Pf | 13 | $2,410 |
| Brimonidine Tartrate | 48 | $2,047 |
| Timolol Maleate | 193 | $1,737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P | $471 | $188,626176 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $304 | $55,77264 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $255 | $11,54619 claims |
| AlconSimbrinza | $487 | $9,31538 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm | $452 | $3,96116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 653 optometrist providers in South Carolina.
Other optometrist in Anderson
- Thomas WeshefskyMyrtle Beach$77K
- Richard BedellCharleston$55K
- Patrick VollmerColumbia$49K
- William ColemanEasley$22K
- Furman SmithMt Pleasant$21K
- Jennifer ZolmanCharleston$21K
- Steven AndreasenGreenville$19K
- Bridget WhaleyGreenville$18K
- Scott OliverRock Hill$16K
- Michael CriswellMount Pleasant$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.